Focused Wealth Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Focused Wealth Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-187	Closed	-$10K	–	769
2017 Q4	$10K	Sell	187 -237	-56%	-$13K	﹤0.01%	477
2017 Q3	$24K	Buy	424 +187	+79%	+$11K	0.01%	329
2017 Q2	$14K	Hold	237	–	–	0.01%	430
2017 Q1	$13K	Buy	+237	New	+$11.7K	0.01%	437

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Focused Wealth Management's BIVV Position: Q1 2018 in Review

Focused Wealth Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 187 shares — an estimated $10K sold.

Focused Wealth Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $24K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Focused Wealth Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Focused Wealth Management sold 187 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $10K.
Focused Wealth Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Focused Wealth Management's Bioverativ Inc. Common Stock position peaked at $24K in Q3 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Focused Wealth Management's 13F filing for Q1 2018, filed 7 May 2018.